NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
49,194,033
Share change
-6,948,920
Total reported value
$92,913,806
Put/Call ratio
20366%
Price per share
$1.89
Number of holders
83
Value change
-$10,321,973
Number of buys
33
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q4 2014

As of 31 Dec 2014, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,194,033 shares. The largest 10 holders included Platinum Management (NY) LLC, Commerzbank Aktiengesellschaft /FI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp. This page lists 83 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.